News
Yorkshire Kidney Screening Trial recruitment success
30 Mar 2022
A trial led by Prof Grant Stewart and Dr Juliet Usher-Smith is assessing the feasibility of scanning the kidneys as well as the lungs to detect early signs of cancer.
Cancer and Artificial Intelligence Podcast
11 Feb 2022
Researchers from the Mark Foundation Institute for Integrated Cancer Medicine discuss how artificial intelligence is making it easier for doctors to diagnose and treat cancer.
Faulty BRCA genes linked to prostate and pancreatic cancers
25 Jan 2022
Faulty versions of the BRCA1 and BRCA2 genes are well known to increase the risk of breast cancer in men and women, and in ovarian cancer. Now BRCA1 and BRCA2 have been linked to several other cancers, including those that affect men.
NICE prostate guidelines updated based on Cambridge research
21 Dec 2021
A Cambridge developed model to risk-categorise prostate cancer has been added to the NICE guidelines and adopted as standard practice in the NHS.
Government funding to use AI to improve cancer care
17 Jun 2021
Two Centre members have been successful in winning government funding to develop AI technologies to improve diagnosis and speed up life-saving cancer treatment.
Targeting kidney cancer screening at people at higher risk shows promise
16 Jun 2021
Recent work at the University of Cambridge on kidney cancer screening, led by Dr Juliet Usher-Smith and Professor Grant Stewart and funded by Kidney Cancer UK, reveals positive public attitudes towards a potential screening programme.
Cambridge-led study introduces kidney scans to Leeds lung screening trial
22 Feb 2021
A new study, led by researchers at the University of Cambridge, will investigate the feasibility of developing a full kidney cancer screening clinical trial.
AI speeds up cancer treatment
9 Dec 2020
Project InnerEye, a collaboration between Addenbrooke's and Microsoft Research, uses AI and machine learning to transform radiotherapy treatment planning.
SORCE kidney cancer trial results published
15 Oct 2020
Active observation remains the best care for kidney cancer patients after surgery.
DNA changes in healthy bladder provide clues on how cancer arises
1 Oct 2020
The first comprehensive study of DNA changes in healthy and diseased human bladder tissue has revealed that ‘cancer-driving’ mutations are common in healthy bladder tissue.